课题基金 / 基金详情

IMPAACT P1066: A PHASE I/II MULTICENTER, OPEN-LABEL, NONCOMPARATIVE STUDY OF

IMPAACT P1066: A PHASE I/II MULTICENTER, OPEN-LABEL, NONCOMPARATIVE STUDY OF
IMPAACT P1066:I/II 期多中心、开放标签、非比较研究
批准号:
8167353
负责人:
Steven L. Zeichner
金额:
$2.19万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-20 至 2010-06-30

项目摘要

项目成果

Steven L. Zeichner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and efficacy or raltegravir in HIV-1 infected children and adolescents, aged 2-19 years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Globally Appropriate Genome Reduced Killed Whole Bacterial HIV Vaccines
  • 批准号:
    10672822
  • 项目类别:
  • 资助金额:
    $56.53万
  • 财政年份:
    2023
  • 负责人:
    Steven L. Zeichner
  • 依托单位:
Pilot Study of Rectal Microbial Biomarkers for Appendicitis Diagnosis
  • 批准号:
    9064769
  • 项目类别:
  • 资助金额:
    $20.71万
  • 财政年份:
    2015
  • 负责人:
    Steven L. Zeichner
  • 依托单位:
Development of an in vivo screening technology for cancer vaccine immunogens
  • 批准号:
    8508685
  • 项目类别:
  • 资助金额:
    $23.02万
  • 财政年份:
    2011
  • 负责人:
    Steven L. Zeichner
  • 依托单位:
Development of an in vivo screening technology for cancer vaccine immunogens
  • 批准号:
    8304214
  • 项目类别:
  • 资助金额:
    $24.49万
  • 财政年份:
    2011
  • 负责人:
    Steven L. Zeichner
  • 依托单位:
海外基金